Key Points
- Insider sale: Debra King sold 826 Stryker shares for approximately $277,784, reducing her position by 11.74% to 6,210 shares.
- Strong quarterly results: Stryker reported earnings of $3.69 per share, exceeding estimates by $0.20, while revenue rose 9.4% year over year to $6.59 billion.
- Market outlook: Analysts maintain a “Moderate Buy” consensus with an average price target of $386.28, while Stryker announced a quarterly dividend of $0.88 per share, yielding about 1.1%.
Stryker Corporation (NYSE:SYK - Get Free Report) insider Debra King sold 826 shares of Stryker stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total value of $277,783.80. Following the transaction, the insider owned 6,210 shares in the company, valued at $2,088,423. This trade represents a 11.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Stryker Price Performance
NYSE SYK opened at $331.96 on Wednesday. The business has a 50 day simple moving average of $325.56 and a 200 day simple moving average of $333.05. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $396.86. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. The stock has a market cap of $127.33 billion, a price-to-earnings ratio of 34.40, a PEG ratio of 2.16 and a beta of 0.76.
Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, beating analysts' consensus estimates of $3.49 by $0.20. The firm had revenue of $6.59 billion for the quarter, compared to analyst estimates of $6.58 billion. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The business's revenue was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Analysts anticipate that Stryker Corporation will post 15.02 earnings per share for the current fiscal year.
Stryker Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a $0.88 dividend. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker's payout ratio is currently 36.48%.
Analysts Set New Price Targets
A number of equities analysts have issued reports on SYK shares. JPMorgan Chase & Co. lowered their target price on Stryker from $400.00 to $350.00 and set an "overweight" rating for the company in a report on Friday, July 31st. Citigroup reaffirmed a "buy" rating on shares of Stryker in a research report on Thursday, August 13th. Leerink Partners decreased their price objective on Stryker from $410.00 to $407.00 and set an "outperform" rating for the company in a report on Friday, June 5th. Deutsche Bank Aktiengesellschaft set a $315.00 target price on Stryker in a research report on Friday, May 1st. Finally, Truist Financial upped their price target on Stryker from $330.00 to $340.00 and gave the stock a "hold" rating in a research report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $386.28.
Read Our Latest Stock Analysis on SYK
Institutional Trading of Stryker
Hedge funds and other institutional investors have recently modified their holdings of the stock. Gables Capital Management Inc. acquired a new position in Stryker in the 2nd quarter valued at about $25,000. Kilter Group LLC bought a new stake in shares of Stryker during the second quarter worth approximately $25,000. Godfrey Financial Associates Inc. bought a new stake in shares of Stryker during the fourth quarter worth approximately $26,000. Sankala Group LLC bought a new position in shares of Stryker during the fourth quarter worth approximately $26,000. Finally, Compass Financial Management LLC acquired a new stake in Stryker during the 2nd quarter worth approximately $27,000. Institutional investors own 77.09% of the company's stock.
Stryker Company Profile
(
Get Free Report)
Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
